Reversible? Don’t Count On It

The “trans” industry’s assault on America’s youth includes persuading kids that they “really” are a boy rather than a girl, or vice versa. Sex change operations don’t come immediately; rather, the preferred sequence begins with puberty-blocking drugs. The rationale is that the effects of these drugs are reversible, so they merely buy time to allow the kid to sort out his or her “gender.”

But are the effects of puberty-blocking drugs actually reversible? Will the boy or girl be magically restored to his or her original self, after a few years in sexual limbo? Many have seen this as a dubious claim, and a number of countries have now banned the administration of puberty blockers along with banning sex change operations on minors. The U.S. is an outlier in our apparent enthusiasm for the “trans” regime.

The Mayo Clinic has now published a study that is getting a lot of attention. Its findings cast doubt on whether puberty blocking is actually reversible. This is from the authors’ abstract of the study:

Spermatogonial stem cell (SSC) acquisition of meiotogenetic state during puberty to produce genetically diverse gametes is blocked by drugs collectively referred as ‘puberty blocker’ (PB). Investigating the impact of PB on juvenile SSC state and function is challenging due to limited tissue access and clinical data. Herein, we report largest clinically annotated juvenile testicular biorepository with all children with gender dysphoria on chronic PB treatment highlighting shift in pediatric patient demography in US. At the tissue level, we report mild-to-severe sex gland atrophy in PB treated children. We developed most extensive integrated single-cell RNA dataset to date (>100K single cells; 25 patients), merging both public and novel (52 month PB-treated) datasets, alongside innovative computational approach tailed for germ cells and evaluated the impact of PB and aging on SSC. We report novel constitutional ranges for each testicular cell type across the entire age spectrum, distinct effects of treatments on prepubertal vs adult SSC, presence of spermatogenic epithelial cells exhibiting post-meiotic-state, irrespective of age, puberty status, or PB treatment. Further, we defined distinct effects of PB and aging on testicular cell lineage composition, and SSC meiotogenetic state and function.

What does it all mean?

This combined with the noted gland atrophy and abnormalities from the histology data raise a potential concern regarding the complete ‘reversibility’ and reproductive fitness of SSC.

The “trans” movement, which seeks to perform medical experiments on our children, is evil. No wonder that those who fall victim to the movement so often commit suicide.

Notice: All comments are subject to moderation. Our comments are intended to be a forum for civil discourse bearing on the subject under discussion. Commenters who stray beyond the bounds of civility or employ what we deem gratuitous vulgarity in a comment — including, but not limited to, “s***,” “f***,” “a*******,” or one of their many variants — will be banned without further notice in the sole discretion of the site moderator.

Responses